306例康艾注射液临床应用合理性评价  

Rationality Evaluation on the Clinical Application of Kang'ai Injection in 306 Cases

作　　者：苏君[1] 石庆平[1] 桑冉[1] 许健[1] SU Jun;SHI Qingping;SANG Ran;XU Jian(Department of Pharmacy,The First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui,China 233004)

机构地区：[1]蚌埠医学院第一附属医院药剂科,安徽蚌埠233004

出　　处：《中国药业》2020年第7期138-141,共4页China Pharmaceuticals

基　　金：蚌埠医学院自然科学基金重点项目[BYKY1828ZD]。

摘　　要：目的调查住院患者使用康艾注射液的情况,为规范其合理使用提供参考。方法采用医院信息系统(HIS)随机等间距抽取医院2018年1月1日至12月31日使用康艾注射液的住院患者病历306份,从使用康艾注射液的适应证、用法用量、用药疗程、溶剂选择、配伍禁忌、联合用药、不良反应等方面进行合理性评价。结果临床使用中,康艾注射液用药频次、用法及用药疗程均合理,不合理使用主要为超适应证用药(114例,37.25%)、剂量过低(14例,4.57%)、溶剂选择不合理(3例,0.98%)、配伍不适宜(17例,5.56%)。结论康艾注射液临床应用存在超适应证用药、剂量过低、溶剂选择不合理、配伍不适宜等问题,需采取干预措施规范其使用。Objective To investigate the application of Kang'ai Injection among inpatients and provide reference for rational and standardized use of this medicine.Methods A total of 306 inpatients who used Kangai injection from January 1,2018 to December 31,2018 were randomly and systematically sampled from a hospital.A rationality evaluation was carried out on the application of Kang'ai Injection in terms of its indications,dosage and administration,course of treatment,solvent selection,incompatibility,concomitant use and adverse reactions.Results Kang'ai Injection was rationally applied in terms of administration frequency,route of administration and course of treatment in clinical practice,while irrational use mainly occurred in the form of over-indication(114 cases,37.25%),insufficient dosage(14 cases,4.57%),irrational selection of solvent(3 cases,0.98%)and incompatibility of medicines(17 cases,5.56%).Conclusion Kang'ai Injection is still misused in clinical practice in the form of over-indication,insufficient dosage,irrational selection of solvent,incompatibility of medicines,etc.Intervention measures need to be adopted to standardize its use.

关 键 词：康艾注射液 临床应用 合理性评价 用药评价 合理用药 

分 类 号：R932[医药卫生—生药学] R288[医药卫生—药学]